Title:The Potential of Graphene Oxide and Reduced Graphene Oxide in
Diagnosis and Treatment of Cancer
Volume: 29
Issue: 26
Author(s): Akram Keramat, Jamileh Kadkhoda, Raheleh Farahzadi, Ezzatollah Fathi and Soodabeh Davaran*
Affiliation:
- Research Center for Pharmaceutical Nanotechnology, Biomedicine Institute, Tabriz University of
Medical Sciences, Tabriz, Iran
Keywords:
Graphene oxide/reduced graphene oxide, cancer diagnosis, targeted delivery, photothermal, biosensor, bioimaging, cell signaling.
Abstract: Nanotechnology is a pioneer field of study for engineering smart nanosystems
in targeted diagnosis and treatment in cancer therapy. Effective treatment for various
types of solid tumors should ideally target malignant cells and tissue while having no effect
on healthy cells in the body. Nano-sized graphene oxide (GO) and reduced graphene
oxide (rGO) have phenomenal chemical versatility, high surface area ratio, and supernatural
physical properties. The synergistic effects caused by the well-defined assembly of
GO and rGO surface generate not only essential optical, mechanical, but also electronic
behaviors. In multimodal cancer therapy, developing innovative multifunctional hybrid
nanoparticles with significant potential is extensively considered. GO and rGO are programmable
targeted delivery systems infused with photonic energy that may be used in
photothermal treatment. Its remarkable properties indicated its applications as a biosensor,
bio-imaging for cancer diagnosis. In this current review, we show a remarkable highlight
about GO, rGO, and discuss the notable applications for cancer diagnosis and treatment,
and provide an overview of possible cellular signaling pathways that are affected
by GO, rGO in cancer treatment.